Kelly Teasdale has moved from AstraZeneca to Burson-Marsteller, becoming a senior director in its UK healthcare practice.
Teasdale joins the agency as a healthcare communications specialist with over 15 years of communications expertise, having held roles at Chandler Chicco Companies Europe, TogoRun and Weber Shandwick.
Most recently, Teasdale served as global brand communications director at AstraZeneca, where she was responsible for the firm’s global patient advocacy and patient-centricity communication strategies for oncology and cardiovascular products.
Kate Hawker, managing director and UK and EMEA healthcare lead for Burson-Marsteller, said: “Kelly is an outstanding global healthcare communications lead and her experience will really help us to develop our capability in key growth areas for us, such as patient centricity and advocacy.”